Exact Mass: 455.9578212

Exact Mass Matches: 455.9578212

Found 19 metabolites which its exact mass value is equals to given mass value 455.9578212, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dihydro-dids

5-isothiocyanato-2-[2-(4-isothiocyanato-2-sulfophenyl)ethyl]benzene-1-sulfonic acid

C16H12N2O6S4 (455.9578212)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels

   

Selumetinib

5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboximidic acid

C17H15BrClFN4O3 (456.00000220000004)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EE - Mitogen-activated protein kinase (mek) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Selumetinib (AZD6244) is selective, non-ATP-competitive oral MEK1/2 inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.

   
   

zinc ethylphenyldithiocarbamate

zinc ethylphenyldithiocarbamate

C18H20N2S4Zn (455.980073)


   

Methyl 3-iodo-1-tosyl-1H-pyrrolo[2,3-b]pyridine-4-carboxylate

Methyl 3-iodo-1-tosyl-1H-pyrrolo[2,3-b]pyridine-4-carboxylate

C16H13IN2O4S (455.96407680000004)


   

butyl-[butyl(sulfanylidene)stannanyl]sulfanyl-sulfanylidenetin

butyl-[butyl(sulfanylidene)stannanyl]sulfanyl-sulfanylidenetin

C8H24S3Sn2 (455.9084044)


   
   

Pentamethylcyclopentadienyltantalum tetrachloride

Pentamethylcyclopentadienyltantalum tetrachloride

C10H15Cl4Ta (455.94079500000004)


   
   

BIS((1,5-CYCLOOCTADIENE)(HYDROXO)RHODIUM)

BIS((1,5-CYCLOOCTADIENE)(HYDROXO)RHODIUM)

C16H26O2Rh2++ (456.0042756)


   

Selumetinib

Selumetinib (AZD6244)

C17H15BrClFN4O3 (456.00000220000004)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EE - Mitogen-activated protein kinase (mek) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Selumetinib (AZD6244) is selective, non-ATP-competitive oral MEK1/2 inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.

   
   

1,4-dimethyl-3-(3,3,3-trichloro-2-methylpropyl)-6-(3,3,3-trichloro-2-methylpropylidene)piperazine-2,5-dione

1,4-dimethyl-3-(3,3,3-trichloro-2-methylpropyl)-6-(3,3,3-trichloro-2-methylpropylidene)piperazine-2,5-dione

C14H18Cl6N2O2 (455.9499388)


   

(3s,6e)-1,4-dimethyl-3-[(2s)-3,3,3-trichloro-2-methylpropyl]-6-[(2s)-3,3,3-trichloro-2-methylpropylidene]piperazine-2,5-dione

(3s,6e)-1,4-dimethyl-3-[(2s)-3,3,3-trichloro-2-methylpropyl]-6-[(2s)-3,3,3-trichloro-2-methylpropylidene]piperazine-2,5-dione

C14H18Cl6N2O2 (455.9499388)


   

(3r,6e)-1,4-dimethyl-3-[(2r)-3,3,3-trichloro-2-methylpropyl]-6-[(2s)-3,3,3-trichloro-2-methylpropylidene]piperazine-2,5-dione

(3r,6e)-1,4-dimethyl-3-[(2r)-3,3,3-trichloro-2-methylpropyl]-6-[(2s)-3,3,3-trichloro-2-methylpropylidene]piperazine-2,5-dione

C14H18Cl6N2O2 (455.9499388)


   

(3s,6z)-1,4-dimethyl-3-[(2s)-3,3,3-trichloro-2-methylpropyl]-6-[(2s)-3,3,3-trichloro-2-methylpropylidene]piperazine-2,5-dione

(3s,6z)-1,4-dimethyl-3-[(2s)-3,3,3-trichloro-2-methylpropyl]-6-[(2s)-3,3,3-trichloro-2-methylpropylidene]piperazine-2,5-dione

C14H18Cl6N2O2 (455.9499388)